Protagenic Therapeutics, Inc.
-
Ticker
PTIX
-
Industry
Networking & Communication Devices More
-
Sector
Technology More
- 1-10 Employees
- Based in New York City, New York
Protagenic Therapeutics, Inc. (OTCQB: PTIX) is a pre-clinical biopharmaceutical company endeavoring to develop first-in-class neuro-active peptides into human therapeutics to treat anxiety, treatment-resistant depression, and other disorders.
Protagenic Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2021 Annual Report and Form 10K
Older/Archived Annual Reports